Clinical trials query results
From Health Canada
- Medical condition:
- PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- VOLRUSTOMIG (MEDI5752)
- Protocol title:
- A PHASE III, RANDOMIZED, OPEN-LABEL, MULTICENTER, GLOBAL STUDY OF VOLRUSTOMIG (MEDI5752) IN COMBINATION WITH CARBOPLATIN PLUS PEMETREXED VERSUS PLATINUM PLUS PEMETREXED OR NIVOLUMAB PLUS IPILIMUMAB IN PARTICIPANTS WITH UNRESECTABLE PLEURAL MESOTHELIOMA (EVOLVE-MESO)
- Sponsor name:
- ASTRAZENECA CANADA INC
- Date of no objection letter:
- 2023-08-17
- Control number:
- 277409
- Trial status:
- ONGOING
- Date study started:
- 2024-04-17